Background And Aim: Focal nodular hyperplasia (FNH) and FNH-like lesions are hypervascular masses that can mimic hepatocellular carcinoma (HCC). We have investigated the clinical, radiological and pathological features of FNH and FNH-like lesions of the liver, with particular focus on the aspect of diagnosis.
Methods: A total of 84 patients, 77 with pathologically-proven FNH and seven with FNH-like lesions of the liver, were analyzed retrospectively.
Results: Of the 84 patients, seven had underlying liver cirrhosis, including two with Budd-Chiari syndrome and one with cardiac cirrhosis. These cases were therefore classified as having FNH-like lesions. Two of the remaining 77 patients without underlying liver cirrhosis were positive for hepatitis B surface antigen. Seven of 50 (14.0%) patients evaluated by four-phase computed tomography (CT) showed portal or delayed washout, and three of 28 (10.7%) patients analyzed by three-phase CT showed washout on the portal phase. Collectively, three of nine (33.3%) patients with risk factors for HCC could have been wrongly diagnosed with HCC based on the non-invasive diagnostic criteria for HCC. A central scar was observed in 30 patients (35.7%) radiologically. Among 62 patients who underwent percutaneous needle biopsy, four patients (6.5%) were misdiagnosed as having HCC and two patients (3.2%) had inconclusive results by a first needle biopsy.
Conclusions: The presence of a hepatic lesion with arterial hypervascularity and/or portal/delayed washout is not necessarily diagnostic of HCC, particularly in patients without risk factors for HCC. These radiological findings can also occur in cirrhotic patients with FNH-like lesions, including those with hepatic outflow obstruction.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1440-1746.2011.06659.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
MRI findings of newly present benign focal hepatic observations following chemotherapy: distinct features in early- and late-term follow-up.
Eur Radiol
November 2024
Department of Radiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Objective: To evaluate gadoxetic acid-enhanced (Gd-EOB-DTPA) MRI features of newly detected benign focal hepatic observations after chemotherapy.
Methods: In this retrospective single-center case-control study, we enrolled a cohort of 43 cancer patients with 93 newly detected benign focal hepatic observations after chemotherapy between January 2010 and December 2020. We evaluated several parameters including the delay of occurrence after chemotherapy, imaging features, and imaging follow-up.
Role of gadoxetic acid-enhanced MRI in the differential diagnosis of chemotherapy-induced focal nodular hyperplasia-like lesions and liver metastases in patients with colorectal cancer.
Abdom Radiol (NY)
September 2024
Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai, China.
Article Synopsis
- The study investigates how gadoxetic acid-enhanced MRI can help identify and differentiate focal nodular hyperplasia (FNH)-like lesions from liver metastases in colorectal cancer patients who underwent chemotherapy.
- A total of 30 patients were analyzed, revealing statistically significant differences in MRI characteristics between FNH-like lesions and liver metastases, with three distinct enhancement patterns observed in FNH-like lesions.
- Follow-up results showed varying outcomes for FNH-like lesions after chemotherapy, with most remaining stable, some growing, and a few reducing or disappearing.
Congestive Hepatopathy: Pathophysiology, Workup, and Imaging Findings with Pathologic Correlation.
Radiographics
May 2024
From the Department of Radiology, Division of Body Imaging, Stanford University School of Medicine, 300 Pasteur Dr, H1307, Stanford, CA 94305 (M.F., A. Kamaya); Department of Radiology, University of Texas MD Anderson Cancer Center, Houston, Tex (K.E.); Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada (A. Kielar, M.S.); Department of Radiology, University of Chicago, Chicago, Ill (C.H.); Department of Radiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio (J.R.D.); Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY (N.H.); Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pa (M.M.); Department of Radiology, Naval Medical Center San Diego, San Diego, Calif (R.M.); and Department of Radiology, Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Ill (A.A.B.).
Liver congestion is increasingly encountered in clinical practice and presents diagnostic pitfalls of which radiologists must be aware. The complex altered hemodynamics associated with liver congestion leads to diffuse parenchymal changes and the development of benign and malignant nodules. Distinguishing commonly encountered benign hypervascular lesions, such as focal nodular hyperplasia (FNH)-like nodules, from hepatocellular carcinoma (HCC) can be challenging due to overlapping imaging features.
View Article and Find Full Text PDFFocal nodular hyperplasia-like nodules arising in the setting of hepatic vascular disorders with portosystemic shunting show β-catenin activation.
Hum Pathol
December 2023
Department of Pathology, University of California, San Francisco, San Francisco, CA, 94143, USA.
Article Synopsis
- Hepatocellular nodules can occur due to chronic liver vascular disorders, especially with conditions like portosystemic shunts (e.g., Abernethy malformation and post-Fontan procedure).
- These nodules vary widely in type, including benign forms (like regenerative nodules and focal nodular hyperplasia) as well as malignant ones (like hepatocellular carcinoma), complicating their classification based on appearance.
- A study of liver resections from patients with such vascular diseases revealed numerous nodule types, including FNH-like nodules that displayed unusual characteristics suggesting they could be neoplastic, highlighting the need for further diagnostic testing to assess cancer risk.
A case of focal nodular hyperplasia-like lesion presenting unusual signal intensity on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance image.
Radiol Case Rep
September 2023
Department of Radiology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan.
Focal nodular hyperplasia (FNH) or FNH-like lesions of the liver are benign lesions that can be mostly diagnosed by hepatobiliary phase gadoxetic acid-enhanced magnetic resonance imaging (MRI). Accurate imaging diagnosis is based on the fact that most FNHs or FNH-like lesions show characteristic hyper- or isointensity on hepatobiliary phase images. We report a case of an FNH-like lesion in a 73-year-old woman that mimicked a malignant tumor.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!